Selected research
Industry Research
Sophorolipid and Rhamnolipid Industry Research Report 2026
Market perspective
The global Sophorolipid and Rhamnolipid market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Sophorolipid and Rhamnolipid is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Sophorolipid and Rhamnolipid is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Sophorolipid and Rhamnolipid is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Sophorolipid and Rhamnolipid include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Sophorolipid and Rhamnolipid market in revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Sophorolipid and Rhamnolipid.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Sophorolipid and Rhamnolipid Market by Company
Allied Carbon Solutions
Saraya
Evonik Industries
Givaudan
Godrej Industries
Holiferm
Stepan
Jeneil Bioproducts GmbH
Shanxi Deguan Biotechnology
Shandong Qilu Biotechnology
Sophorolipid and Rhamnolipid Segment by Type
Sophorolipid
Rhamnolipid
Sophorolipid and Rhamnolipid Segment by Application
Household Detergents
Personal Care
Industrial
Food & Beverage
Pharmaceuticals
Others
Sophorolipid and Rhamnolipid Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sophorolipid and Rhamnolipid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sophorolipid and Rhamnolipid and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sophorolipid and Rhamnolipid.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Sophorolipid and Rhamnolipid manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Sophorolipid and Rhamnolipid by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Sophorolipid and Rhamnolipid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Sophorolipid
- Rhamnolipid
Applications
- Household Detergents
- Personal Care
- Industrial
- Food & Beverage
- Pharmaceuticals
- Others
Companies covered
- Allied Carbon Solutions
- Saraya
- Evonik Industries
- Givaudan
- Godrej Industries
- Holiferm
- Stepan
- Jeneil Bioproducts GmbH
- Shanxi Deguan Biotechnology
- Shandong Qilu Biotechnology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Sophorolipid and Rhamnolipid by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Sophorolipid
- 2.2.3 Rhamnolipid
- 2.3 Sophorolipid and Rhamnolipid by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Household Detergents
- 2.3.3 Personal Care
- 2.3.4 Industrial
- 2.3.5 Food & Beverage
- 2.3.6 Pharmaceuticals
- 2.3.7 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Sophorolipid and Rhamnolipid Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Sophorolipid and Rhamnolipid Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Sophorolipid and Rhamnolipid Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Sophorolipid and Rhamnolipid Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Sophorolipid and Rhamnolipid Production by Manufacturers (2021-2026)
- 3.2 Global Sophorolipid and Rhamnolipid Production Value by Manufacturers (2021-2026)
- 3.3 Global Sophorolipid and Rhamnolipid Average Price by Manufacturers (2021-2026)
- 3.4 Global Sophorolipid and Rhamnolipid Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Sophorolipid and Rhamnolipid Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Sophorolipid and Rhamnolipid Manufacturers, Product Type & Application
- 3.7 Global Sophorolipid and Rhamnolipid Manufacturers Established Date
- 3.8 Global Sophorolipid and Rhamnolipid Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Allied Carbon Solutions
- 4.1.1 Allied Carbon Solutions Sophorolipid and Rhamnolipid Company Information
- 4.1.2 Allied Carbon Solutions Sophorolipid and Rhamnolipid Business Overview
- 4.1.3 Allied Carbon Solutions Sophorolipid and Rhamnolipid Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Allied Carbon Solutions Product Portfolio
- 4.1.5 Allied Carbon Solutions Recent Developments
- 4.2 Saraya
- 4.2.1 Saraya Sophorolipid and Rhamnolipid Company Information
- 4.2.2 Saraya Sophorolipid and Rhamnolipid Business Overview
- 4.2.3 Saraya Sophorolipid and Rhamnolipid Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Saraya Product Portfolio
- 4.2.5 Saraya Recent Developments
- 4.3 Evonik Industries
- 4.3.1 Evonik Industries Sophorolipid and Rhamnolipid Company Information
- 4.3.2 Evonik Industries Sophorolipid and Rhamnolipid Business Overview
- 4.3.3 Evonik Industries Sophorolipid and Rhamnolipid Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Evonik Industries Product Portfolio
- 4.3.5 Evonik Industries Recent Developments
- 4.4 Givaudan
- 4.4.1 Givaudan Sophorolipid and Rhamnolipid Company Information
- 4.4.2 Givaudan Sophorolipid and Rhamnolipid Business Overview
- 4.4.3 Givaudan Sophorolipid and Rhamnolipid Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Givaudan Product Portfolio
- 4.4.5 Givaudan Recent Developments
- 4.5 Godrej Industries
- 4.5.1 Godrej Industries Sophorolipid and Rhamnolipid Company Information
- 4.5.2 Godrej Industries Sophorolipid and Rhamnolipid Business Overview
- 4.5.3 Godrej Industries Sophorolipid and Rhamnolipid Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Godrej Industries Product Portfolio
- 4.5.5 Godrej Industries Recent Developments
- 4.6 Holiferm
- 4.6.1 Holiferm Sophorolipid and Rhamnolipid Company Information
- 4.6.2 Holiferm Sophorolipid and Rhamnolipid Business Overview
- 4.6.3 Holiferm Sophorolipid and Rhamnolipid Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Holiferm Product Portfolio
- 4.6.5 Holiferm Recent Developments
- 4.7 Stepan
- 4.7.1 Stepan Sophorolipid and Rhamnolipid Company Information
- 4.7.2 Stepan Sophorolipid and Rhamnolipid Business Overview
- 4.7.3 Stepan Sophorolipid and Rhamnolipid Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Stepan Product Portfolio
- 4.7.5 Stepan Recent Developments
- 4.8 Jeneil Bioproducts GmbH
- 4.8.1 Jeneil Bioproducts GmbH Sophorolipid and Rhamnolipid Company Information
- 4.8.2 Jeneil Bioproducts GmbH Sophorolipid and Rhamnolipid Business Overview
- 4.8.3 Jeneil Bioproducts GmbH Sophorolipid and Rhamnolipid Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Jeneil Bioproducts GmbH Product Portfolio
- 4.8.5 Jeneil Bioproducts GmbH Recent Developments
- 4.9 Shanxi Deguan Biotechnology
- 4.9.1 Shanxi Deguan Biotechnology Sophorolipid and Rhamnolipid Company Information
- 4.9.2 Shanxi Deguan Biotechnology Sophorolipid and Rhamnolipid Business Overview
- 4.9.3 Shanxi Deguan Biotechnology Sophorolipid and Rhamnolipid Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 Shanxi Deguan Biotechnology Product Portfolio
- 4.9.5 Shanxi Deguan Biotechnology Recent Developments
- 4.10 Shandong Qilu Biotechnology
- 4.10.1 Shandong Qilu Biotechnology Sophorolipid and Rhamnolipid Company Information
- 4.10.2 Shandong Qilu Biotechnology Sophorolipid and Rhamnolipid Business Overview
- 4.10.3 Shandong Qilu Biotechnology Sophorolipid and Rhamnolipid Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Shandong Qilu Biotechnology Product Portfolio
- 4.10.5 Shandong Qilu Biotechnology Recent Developments
5 Global Sophorolipid and Rhamnolipid Production by Region
- 5.1 Global Sophorolipid and Rhamnolipid Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Sophorolipid and Rhamnolipid Production by Region: 2021-2032
- 5.2.1 Global Sophorolipid and Rhamnolipid Production by Region: 2021-2026
- 5.2.2 Global Sophorolipid and Rhamnolipid Production Forecast by Region (2027-2032)
- 5.3 Global Sophorolipid and Rhamnolipid Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Sophorolipid and Rhamnolipid Production Value by Region: 2021-2032
- 5.4.1 Global Sophorolipid and Rhamnolipid Production Value by Region: 2021-2026
- 5.4.2 Global Sophorolipid and Rhamnolipid Production Value Forecast by Region (2027-2032)
- 5.5 Global Sophorolipid and Rhamnolipid Market Price Analysis by Region (2021-2026)
- 5.6 Global Sophorolipid and Rhamnolipid Production and Value, YOY Growth
- 5.6.1 North America Sophorolipid and Rhamnolipid Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Sophorolipid and Rhamnolipid Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Sophorolipid and Rhamnolipid Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Sophorolipid and Rhamnolipid Production Value Estimates and Forecasts (2021-2032)
6 Global Sophorolipid and Rhamnolipid Consumption by Region
- 6.1 Global Sophorolipid and Rhamnolipid Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Sophorolipid and Rhamnolipid Consumption by Region (2021-2032)
- 6.2.1 Global Sophorolipid and Rhamnolipid Consumption by Region: 2021-2026
- 6.2.2 Global Sophorolipid and Rhamnolipid Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Sophorolipid and Rhamnolipid Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Sophorolipid and Rhamnolipid Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Sophorolipid and Rhamnolipid Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Sophorolipid and Rhamnolipid Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Sophorolipid and Rhamnolipid Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Sophorolipid and Rhamnolipid Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Sophorolipid and Rhamnolipid Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Sophorolipid and Rhamnolipid Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Sophorolipid and Rhamnolipid Production by Type (2021-2032)
- 7.1.1 Global Sophorolipid and Rhamnolipid Production by Type (2021-2032) & (Tons)
- 7.1.2 Global Sophorolipid and Rhamnolipid Production Market Share by Type (2021-2032)
- 7.2 Global Sophorolipid and Rhamnolipid Production Value by Type (2021-2032)
- 7.2.1 Global Sophorolipid and Rhamnolipid Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Sophorolipid and Rhamnolipid Production Value Market Share by Type (2021-2032)
- 7.3 Global Sophorolipid and Rhamnolipid Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Sophorolipid and Rhamnolipid Production by Application (2021-2032)
- 8.1.1 Global Sophorolipid and Rhamnolipid Production by Application (2021-2032) & (Tons)
- 8.1.2 Global Sophorolipid and Rhamnolipid Production Market Share by Application (2021-2032)
- 8.2 Global Sophorolipid and Rhamnolipid Production Value by Application (2021-2032)
- 8.2.1 Global Sophorolipid and Rhamnolipid Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Sophorolipid and Rhamnolipid Production Value Market Share by Application (2021-2032)
- 8.3 Global Sophorolipid and Rhamnolipid Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Sophorolipid and Rhamnolipid Value Chain Analysis
- 9.1.1 Sophorolipid and Rhamnolipid Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Sophorolipid and Rhamnolipid Production Mode & Process
- 9.2 Sophorolipid and Rhamnolipid Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Sophorolipid and Rhamnolipid Distributors
- 9.2.3 Sophorolipid and Rhamnolipid Customers
10 Global Sophorolipid and Rhamnolipid Analyzing Market Dynamics
- 10.1 Sophorolipid and Rhamnolipid Industry Trends
- 10.2 Sophorolipid and Rhamnolipid Industry Drivers
- 10.3 Sophorolipid and Rhamnolipid Industry Opportunities and Challenges
- 10.4 Sophorolipid and Rhamnolipid Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst